Companies are often so keenly focused on developing the product inside the box that they can sometimes miss critical requirements for the package that is intended to protect it.
Watch Now
nvidia
In this webinar, OMDIA, Hewlett Packard Enterprise and NVIDIA experts will focus on how AI will act as a catalyst to enable the new wave of capabilities and the investments being made now to take advantage of machine learning and state-of-the-art computing.
Watch Now
Cancerresearch
Small cell lung cancer (SCLC) is aggressive and often difficult to treat, but many patients may have new hope. On August 17, 2018, the FDA approved the first immunotherapy the checkpoint inhibitor nivolumab (Opdivo, Bristol-Myers Squibb for patients with small cell lung cancer. Since this approval, there has been renewed focus on how to make different immunotherapies work for a disease which typicallly comprises 10-15% of all lung cancer cases. In this webinar for patients and caregivers, Matthew Hellmann, M.D., of Memorial Sloan Kettering Cancer Center discusses the new FDA approval, clinical trials, and potential treatments for patients with small cell lung cancer.
Watch Now
HIMSS Media
With the surge in EMR usage, keyboards and PCs are used widely in clinical care settings. But unlike medical equipment and high-touch environmental surfaces, these IT devices are rarely subject to infection prevention standards. Studies have demonstrated that over 80% of these devices might have significant microbial contamination which may include nosocomial pathogens like vancomycin-resistant Enterococcus species (VRE). Coupled with low (40%) compliance with the CDC's guidelines on hand hygiene, these ubiquitous computers and keyboards can lead to cross-contamination of patients.
Watch Now